These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21861097)

  • 21. Atypical onset of symptoms in Huntington disease: severe cognitive decline preceding chorea or other motor manifestations.
    Cooper DB; Ales G; Lange C; Clement P
    Cogn Behav Neurol; 2006 Dec; 19(4):222-4. PubMed ID: 17159620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Executive dysfunction in Huntington's disease].
    Redondo Vergé L; Brown RG; Chacón J
    Rev Neurol; 2001 May 16-31; 32(10):923-9. PubMed ID: 11424047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emotion Evaluation and Social Inference Impairments in Huntington's Disease.
    Philpott AL; Andrews SC; Staios M; Churchyard A; Fisher F
    J Huntingtons Dis; 2016 May; 5(2):175-83. PubMed ID: 27163947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Cognition and Cortical Excitability in Huntington's Disease.
    Kamble N; Netravathi M; Nagaraju BC; Lenka A; Kumar K; Sowmya V; Jain S; Pal PK
    Can J Neurol Sci; 2018 Mar; 45(2):176-181. PubMed ID: 29307324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities.
    Hoth KF; Paulsen JS; Moser DJ; Tranel D; Clark LA; Bechara A
    J Clin Exp Neuropsychol; 2007 May; 29(4):365-76. PubMed ID: 17497560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of oculomotor functioning on neuropsychological performance in Huntington disease.
    Carvalho JO; Long JD; Westervelt HJ; Smith MM; Bruce JM; Kim JI; Mills JA; Paulsen JS;
    J Clin Exp Neuropsychol; 2016; 38(2):217-26. PubMed ID: 26745770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
    McAllister B; Gusella JF; Landwehrmeyer GB; Lee JM; MacDonald ME; Orth M; Rosser AE; Williams NM; Holmans P; Jones L; Massey TH;
    Neurology; 2021 May; 96(19):e2395-e2406. PubMed ID: 33766994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
    Scahill RI; Hobbs NZ; Say MJ; Bechtel N; Henley SM; Hyare H; Langbehn DR; Jones R; Leavitt BR; Roos RA; Durr A; Johnson H; Lehéricy S; Craufurd D; Kennard C; Hicks SL; Stout JC; Reilmann R; Tabrizi SJ;
    Hum Brain Mapp; 2013 Mar; 34(3):519-29. PubMed ID: 22102212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
    Stout JC; Jones R; Labuschagne I; O'Regan AM; Say MJ; Dumas EM; Queller S; Justo D; Santos RD; Coleman A; Hart EP; Dürr A; Leavitt BR; Roos RA; Langbehn DR; Tabrizi SJ; Frost C
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):687-94. PubMed ID: 22566599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor insight into memory impairment in patients with Huntington disease.
    Sitek EJ; Sołtan W; Robowski P; Schinwelski M; Wieczorek D; Sławek J
    Neurol Neurochir Pol; 2012; 46(4):318-25. PubMed ID: 23023430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability in cognitive function among persons at high genetic risk of Huntington's disease.
    Lundervold AJ; Reinvang I
    Acta Neurol Scand; 1995 Jun; 91(6):462-9. PubMed ID: 7572041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
    Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
    J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairments to executive function in emerging adults with Huntington disease.
    Pfalzer AC; Watson KH; Ciriegio AE; Hale L; Diehl S; McDonell KE; Vnencak-Jones C; Huitz E; Snow A; Roth MC; Guthrie CS; Riordan H; Long JD; Compas BE; Claassen DO
    J Neurol Neurosurg Psychiatry; 2023 Feb; 94(2):130-135. PubMed ID: 36450478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of two brief screening measures of cognitive impairment in Huntington's disease.
    Mickes L; Jacobson M; Peavy G; Wixted JT; Lessig S; Goldstein JL; Corey-Bloom J
    Mov Disord; 2010 Oct; 25(13):2229-33. PubMed ID: 20721924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.
    Ross CA; Pantelyat A; Kogan J; Brandt J
    Mov Disord; 2014 Sep; 29(11):1351-8. PubMed ID: 25216368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Huntington study group's neuropsychology working group position on best practice recommendations for the clinical neuropsychological evaluation of patients with Huntington disease.
    Considine CM; Rossetti MA; Anderson K; Del Bene VA; Anderson SA; Celka AS; Edmondson MC; Sheese ALN; Piccolino A; Teixeira AL; Stout JC
    Clin Neuropsychol; 2024 May; 38(4):984-1006. PubMed ID: 37849335
    [No Abstract]   [Full Text] [Related]  

  • 38. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
    Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
    Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological markers of cognition in prodromal Huntington's disease: a review.
    Papp KV; Kaplan RF; Snyder PJ
    Brain Cogn; 2011 Nov; 77(2):280-91. PubMed ID: 21889251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.